General Information of the Compound
Compound ID
CP0453535
Compound Name
N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)-2-pyridin-2-ylacetamide
    Show/Hide
Structure
Formula
C18H13ClN4O
Molecular Weight
336.782
Canonical SMILES
Clc1cc(NC(=O)Cc2ccccn2)c2[nH]c3cnccc3c2c1
    Show/Hide
InChI
InChI=1S/C18H13ClN4O/c19-11-7-14-13-4-6-20-10-16(13)23-18(14)15(8-11)22-17(24)9-12-3-1-2-5-21-12/h1-8,10,23H,9H2,(H,22,24)
    Show/Hide
InChIKey
KNFPDDQBEKGJKM-UHFFFAOYSA-N
Physicochemical Property
logP
3.9457
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
70.67
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 21362687
ChEMBL ID
CHEMBL82136
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01239, Inhibitor of nuclear factor kappa-B kinase subunit alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 3000 nM
   TI
   LI
   LO
   TS